₹387.85
8.95 (2.36%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹6.31K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
21.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹312.95+23.9%
52W High₹527.8-26.5%
Current Price
₹387.85
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹310.28
Upper Circuit₹465.42
Reference Price
₹387.85
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹384.5
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹380.55
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
EMA(20) Crossover: Price crossed above EMA(20): Fresh bullish momentum signal.
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
80%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
384.39
EMA50
375.16
EMA200
400.56
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹389.00
₹399.50
₹404.85
₹422.00
₹431.80
Support (Below)
₹385.00
₹376.30
₹359.20
₹353.80
₹349.25
Volume Analysis
TrendDECREASING
Change-48.60%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹383.97
3% Risk₹376.21
5% Risk₹368.46
7% Risk (Custom)
₹360.70Technical Levels
1x ATR (Volatility)₹370.77
2x ATR (Swing)₹353.69
3x ATR (Trend)₹336.61
Immediate Support₹385.00
Moving Averages
EMA 9 (Short-term)₹386.78
EMA 20 (Medium-term)₹384.39
EMA 50 (Trend)₹375.16
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹486.3 Cr | ₹648.4 Cr | ₹473 Cr | ₹464.7 Cr |
| Net Profit | ₹38.7 Cr | ₹121.4 Cr | ₹28.4 Cr | ₹28.3 Cr |
| EPS | — | ₹7.45 | ₹1.75 | ₹1.74 |
| Operating Profit | ₹69.3 Cr | ₹175.8 Cr | ₹54.4 Cr | ₹52.3 Cr |
ROE
11.70%
ROCE
15.68%
Debt/Equity
0.01
Current Ratio
3.01
OPM
11.25%
NPM
6.09%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 11 Feb 2026 | Interim Dividend - Rs 5 Per Share | INTERIM_DIVIDEND |
| 22 Nov 2024 | Interim Dividend - Rs 5 Per Share | INTERIM_DIVIDEND |
| 19 Sept 2024 | Annual General Meeting | AGM |
| 20 Sept 2023 | Annual General Meeting | AGM |
| 25 Aug 2023 | Buy Back | BUYBACK |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for FDC
View AllNEWS
positive
Business Standard - Markets 16d ago
FDC consolidated net profit rises 167.39% in the March 2026 quarter
Sales rise 18.89% to Rs 584.79 crore
FDCHealthcare